2013 BRFSS Asthma Call-Back Survey Prevalence Tables

TABLE 6. Estimated percent receiving an asthma management plan among adults1 with current2 or active3 asthma status by state/territory – BRFSS Asthma Call-back Survey Land Line Sample, United States, 2013

State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Alabama 133 35.0 8.8 (17.8 – 52.2) 140 29.4 8.2 (13.3 – 45.5)
Arizona 101 N/A N/A (N/A – N/A) 104 N/A N/A (N/A – N/A)
California 167 28.5 5.8 (17.1 – 39.9) 183 28.8 5.4 (18.2 – 39.4)
Connecticut 208 28.5 5.0 (18.7 – 38.3) 227 29.2 4.8 (19.8 – 38.6)
Florida 720 26.4 4.8 (17.0 – 35.8) 762 28.0 4.8 (18.6 – 37.4)
Georgia 123 30.8 7.6 (15.9 – 45.7) 132 29.3 7.3 (15.0 – 43.6)
Hawaii 109 N/A N/A (N/A – N/A) 109 40.7 11.3 (18.6 – 62.8)
Indiana 318 31.6 5.3 (21.2 – 42.0) 333 31.1 5.0 (21.3 – 40.9)
Iowa 203 39.6 7.5 (24.9 – 54.3) 207 40.0 7.2 (25.9 – 54.1)
Kansas 621 27.5 3.4 (20.8 – 34.2) 651 27.2 3.3 (20.7 – 33.7)
Kentucky 328 23.8 3.8 (16.4 – 31.2) 357 23.9 3.6 (16.8 – 31.0)
Louisiana 124 28.9 7.3 (14.6 – 43.2) 142 23.5 6.5 (10.8 – 36.2)
Maine 220 32.1 5.7 (20.9 – 43.3) 238 30.4 5.3 (20.0 – 40.8)
Maryland 224 18.6 4.5 (9.8 – 27.4) 241 19.9 4.4 (11.3 – 28.5)
Massachusetts 140 N/A N/A (N/A – N/A) 148 39.7 10.3 (19.5 – 59.9)
Michigan 452 34.7 4.3 (26.3 – 43.1) 484 34.7 4.2 (26.5 – 42.9)
Mississippi 200 30.6 8.7 (13.5 – 47.7) 203 30.3 8.8 (13.1 – 47.5)
Missouri 209 27.9 6.4 (15.4 – 40.4) 216 28.3 6.3 (16.0 – 40.6)
Montana 252 N/A N/A (N/A – N/A) 274 28.4 7.8 (13.1 – 43.7)
Nebraska 263 19.6 5.0 (9.8 – 29.4) 284 23.1 5.5 (12.3 – 33.9)
Nevada 96 20.9 6.0 (9.1 – 32.7) 111 24.2 6.4 (11.7 – 36.7)
New Hampshire 214 29.1 5.8 (17.7 – 40.5) 228 29.6 5.6 (18.6 – 40.6)
New Jersey 247 43.4 6.8 (30.1 – 56.7) 278 37.4 6.4 (24.9 – 49.9)
New Mexico 218 30.7 6.2 (18.5 – 42.9) 233 29.2 6.1 (17.2 – 41.2)
New York 110 40.3 8.8 (23.1 – 57.5) 111 35.3 7.9 (19.8 – 50.8)
North Carolina 105 34.5 8.3 (18.2 – 50.8) 120 37.1 8.1 (21.2 – 53.0)
Ohio 245 29.5 5.7 (18.3 – 40.7) 256 27.5 5.4 (16.9 – 38.1)
Oklahoma 224 27.4 4.8 (18.0 – 36.8) 234 24.3 4.1 (16.3 – 32.3)
Oregon 163 19.6 4.4 (11.0 – 28.2) 181 19.5 4.3 (11.1 – 27.9)
Pennsylvania 249 37.0 6.1 (25.0 – 49.0) 267 34.7 5.7 (23.5 – 45.9)
Rhode Island 196 24.3 4.7 (15.1 – 33.5) 208 22.5 4.2 (14.3 – 30.7)
Texas 205 30.0 7.5 (15.3 – 44.7) 229 37.8 8.0 (22.1 – 53.5)
Utah 304 25.3 5.3 (14.9 – 35.7) 318 25.3 5.1 (15.3 – 35.3)
Vermont 188 20.7 4.6 (11.7 – 29.7) 199 20.4 4.5 (11.6 – 29.2)
Washington 282 19.4 3.3 (12.9 – 25.9) 290 21.3 3.5 (14.4 – 28.2)
West Virginia 121 21.7 5.3 (11.3 – 32.1) 120 21.7 5.4 (11.1 – 32.3)
Wisconsin 186 29.0 5.8 (17.6 – 40.4) 185 25.2 5.8 (13.8 – 36.6)
Puerto Rico 204 47.7 6.5 (35.0 – 60.4) 245 41.0 5.8 (29.6 – 52.4)
38 state total 8,672 31.0 1.6 (27.9 – 34.1) 9,248 30.8 1.5 (27.9 – 33.7)
Median   29.0       28.8    
Range   18.6-47.7       19.5-41.0    

1 Aged ≥ 18 years

2 “Yes” response to “Do you still have asthma?”

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Landline sample size excludes “DK/Refused”

§ Standard error

Confidence interval

N/A: Estimate not available (N/A) if the unweighted sample size for the denominator was < 50 or if the relative standard error was > 0.30